Sinclair Pharma PLC Director/PDMR Shareholding (0601C)

TIDMSPH

RNS Number : 0601C

Sinclair Pharma PLC

17 January 2018

Sinclair Pharma plc

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

London, 17 January 2018 Sinclair Pharma plc (AIM:SPH.L) ("Sinclair" or the "Group"), the international aesthetics company, was advised on 16 January 2018, that on that day, Jeff Thompson, Non-Executive Director, acquired 200,000 ordinary shares of 1p each ("Ordinary Shares") in the Group at an average price of 23.1p per Ordinary Share.

Following these purchases, Jeff Thompson's total beneficial interest is 350,000 Ordinary Shares, 0.07% of the issued share capital of the Group.

For further information please contact:

 
 Sinclair Pharma   Tel: +44 (0) 
  plc               20 7467 6920 
 Chris Spooner 
 Alan Olby 
 Andy Crane 
 
 
 Peel Hunt LLP (NOMAD and   Tel: [phone] 
  Joint Broker)                     8900 
 James Steel 
 Oliver Jackson 
 
 
 RBC Capital Markets (Joint   Tel: [phone] 
  Broker)                             4000 
 Marcus Jackson 
 Laura White 
 
 
 
 1.   Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ---------------------------------------------------------------- 
 a.   Name                            Jeff Thompson 
---  ------------------------------  -------------------------------- 
 2.   Reason for the notification 
---  ---------------------------------------------------------------- 
 a.   Position/status                 Non-Executive Director 
---  ------------------------------  -------------------------------- 
 b.   Initial                         Initial Announcement 
       notification 
       /Amendment 
---  ------------------------------  -------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  ---------------------------------------------------------------- 
 a.   Name                            Sinclair Pharma plc 
---  ------------------------------  -------------------------------- 
 b.   LEI                             213800BNMD7JVMHW1772 
---  ------------------------------  -------------------------------- 
 4.   Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ---------------------------------------------------------------- 
 a.   Description                     Ordinary Shares of 1 pence each 
       of the                          in Sinclair Pharma plc 
       Financial 
       instrument, 
       type 
       of instrument                   GB0033856740 
       Identification 
       code 
---  ------------------------------  -------------------------------- 
 b.   Nature of                       Purchase 
       the transaction 
---  ------------------------------  -------------------------------- 
 c.   Price(s)                          Price(s)   Volume(s) 
       and volume(s)                    ---------  ---------- 
                                         23.1p      200,000 
                                        ---------  ---------- 
---  ------------------------------  -------------------------------- 
 d.        Aggregated 
            information                            N/A 
             *    Aggregated volume 
 
 
             *    Price 
---  ------------------------------  -------------------------------- 
 e.   Date of                         2018-01-16 
       the transaction 
---  ------------------------------  -------------------------------- 
 f.   Place of                        London Stock Exchange, AIM 
       the transaction 
---  ------------------------------  -------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHDQLFFVFFLBBD

(END) Dow Jones Newswires

January 17, 2018 02:00 ET (07:00 GMT)